The European Medicines Agency (EMA) could issue an opinion on the COVID-19 vaccine co-developed by AstraZeneca and the University of Oxford as early as 29 January, according to a press release the ...
Are we still going to use it? Can we just scrap it? Do we have enough Pfizer? With more changing health advice and discussion ...
Hosted on MSN
Moderna, Pfizer, Sanofi In Focus As US Winds Down mRNA Vaccine Plans; Retail Turns Bearish On AstraZeneca
Shares of Moderna (MRNA), Pfizer (PFE), and Sanofi (SNY) drew increased attention on Tuesday as traders reacted to the U.S. government’s move to halt future mRNA vaccine development under the ...
Wall Street’s major market averages ended near even on Friday as traders digested the latest round of key retail inflation data. The blue-chip Dow ended +0.1%. At the same time, the benchmark S&P 500 ...
LONDON -AstraZeneca is paying up to $157 million, plus royalties, for an exclusive licence to develop and sell a set of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results